CODEXIS, INC.

CDXS Net selling

CIK 0001200375 #4030 in the set updated 17 Sep 2026

Bought (120 mo)

$14.56M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$54.07M

$0.00 on a plan · $24.58M straight out of an exercise

Sold at will

$29.49M

123 of 187 sales

Net

−$39.52M

−$14.94M against sales at will

By person

29 insiders · 244 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

NICOLS JOHN J

Director

$266.00K (2)

$16.21M (47) scheduled

−$15.94M

783,965

0.7159%

$1.86M

−12.0%

Opaleye Management Inc. entity

10% owner

$13.74M (44)

$4.85M (15)

+$8.89M

179,989

0.1644%

$426.57K

—

Vivo Ventures Fund VII, L.P. entity

10% owner

—

$6.12M (2)

−$6.12M

4,234,825

3.87%

$10.04M

−20.0%

Yang Patrick Y

Director

$396.92K (5)

$6.07M (14)

−$5.67M

53,785

0.0491%

$127.47K

−82.1%

SANGSTER GORDON

SVP & Chief Financial Officer

—

$4.85M (9) scheduled

−$4.85M

134,453

0.1228%

$318.65K

+6.5%

Dorgan Byron L

Director

—

$3.35M (10) scheduled

−$3.35M

223,581

0.2042%

$529.89K

+26.5%

WOLF DENNIS P

Director

—

$3.25M (23)

−$3.25M

138,951

0.1269%

$329.31K

+12.6%

BARUCH THOMAS R

Director

—

$2.65M (16)

−$2.65M

33,093

0.0302%

$78.43K

−81.5%

KELLEY BERNARD J

Director

—

$2.29M (15) scheduled

−$2.29M

206,136

0.1882%

$488.54K

−14.8%

Lalonde James

SVP, R&D

—

$1.98M (12)

−$1.98M

133,402

0.1218%

$316.16K

−30.3%

Glaub Kathleen Sereda

Director

—

$786.61K (3)

−$786.61K

68,481

0.0625%

$162.30K

−18.8%

Aldridge Michael D.

See Remarks

—

$581.81K (2) scheduled

−$581.81K

0

0.0000%

$0.00

—

Cheng Pam P.

Director

—

$549.78K (3)

−$549.78K

69,589

0.0635%

$164.93K

−13.1%

DILLY STEPHEN GEORGE

Director

$100.95K (1)

$252.21K (2)

−$151.26K

727,053

0.6639%

$1.72M

+12,018%

Smith David V

Director

—

$62.21K (1)

−$62.21K

238,885

0.2181%

$566.16K

+107.1%

Norrett Kevin

Chief Operating Officer

$15.48K (1)

$77.18K (2)

−$61.70K

177,327

0.1619%

$420.26K

—

Fitzgerald Margaret Nell

See Remarks

$20.06K (1)

$71.83K (2)

−$51.77K

133,770

0.1222%

$317.03K

—

MOORE ALISON

President and CEO

—

$20.63K (2)

−$20.63K

250,506

0.2288%

$593.70K

—

Erbez Georgia

See Remarks

—

$20.63K (2)

−$20.63K

66,810

0.0610%

$158.34K

—

Ryali Sriram

Chief Financial Officer

$19.86K (1)

—

+$19.86K

175,791

0.1605%

$416.62K

—

Lutz Stefan

Chief Scientific Officer

—

$17.85K (3)

−$17.85K

130,421

0.1191%

$309.10K

−9.1%

De Vre Raymond

Director

—

$8.63K (2)

−$8.63K

84,811

0.0774%

$201.00K

—

PARKER H STEWART

Director

—

—

—

143,583

0.1311%

$340.29K

—

Singhvi Rahul

Director

—

—

—

137,052

0.1252%

$324.81K

—

Martinborough Esther

Director

—

—

—

129,036

0.1178%

$305.82K

—

Collins Cynthia

Director

—

—

—

112,157

0.1024%

$265.81K

—

Richards Christos

Director

—

—

—

85,133

0.0777%

$201.77K

—

Aaker Jennifer

Director

—

—

—

66,211

0.0605%

$156.92K

—

TAYLOR DEAN ROSS JR

Advisor

—

—

—

38,554

0.0352%

$91.37K

—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 287

Amendments (4/A) skipped 7

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 64

Sales at will 123

Transactions with no price 0

Shares from compensation/vesting 5,603,448

Sales filed before the plan box existed 97

History held since 12 Sep 2016